Advocacy Through Access Part 6: Overcoming the Myths of Healthcare Convention Measurement
Healthcare convention measurement is often surrounded by myths, misconceptions, and hesitation. Yet, for small pharmaceutical, biotech, medical device, and diagnostics companies, measuring the success of healthcare meetings is vital — especially when preparing for...
Advocacy Through Access Part 5: Three Ways the Sustainability Movement Could Save Medical Conventions
Trouble is Brewing Exhibit industry press claims convention attendance and event space are back to pre-pandemic levels. But corporate marketers share a different reality: budgets are stagnant, service costs are excruciatingly high and unpredictable, travel...
Advocacy Through Access Part 4: Clinical Stage Marketers, This is for You!
For clinical-stage companies working to get their products over the finish line, national congresses can be a goldmine of opportunities: credibility, visibility, access to key opinion leaders and other hard-to-reach clinicians, engagement with patient advocacy groups,...